Discovery On Target 2023: Meet us in Boston

2023.09.12

Axcelead will be exhibiting at upcoming Discovery On Target 2023 in Boston. Visit us at Booth #200 to learn how we can empower your drug discovery. Our team looks forward to meeting you there!

Date: September 25 – 28, 2023
Venue: Sheraton Boston
Booth No. #200

■ Presentation in symposium
Axcelead will also be presenting at the Strategies for Targeting Kinases Symposium on 9/25!

Date: Monday, September 25　14:30 – 14:45
Title: Axcelead Kinase Inhibitor Discovery Platform: Identification of Selective Inhibitors for 123 Kinases
Presenter: Akito Hata, Director, Discovery Biology, Axcelead Drug Discovery Partners, Inc.

Abstract:
Axcelead, a spin-off from a Japanese pharmaceutical company, is a CRO with comprehensive preclinical research capabilities. Our uniqueness stems from inherited 1.5 million compound library and retaining access to legacy data prior to the company separation. Here, we present approaches that are used to discover potent and selective inhibitors for 123 protein kinases: internal protein kinase panel database, kinase-focused library for selective hit identification, and Mini Kinase Panel 46.

■ Poster
In-Person Presenter will remain by our poster during refreshment breaks.

P006: Discovery of Selective Inhibitors for 123 Protein Kinases Utilizing Internal Kinase Panel Dataset
Presenter: Akito Hata, Director, Discovery Biology, Axcelead Drug Discovery Partners, Inc.